V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310006711 | 310003904 | 1.7 | 7 | Unknown (U) | 2013-06-18 | 2013-07-02 | CARBOPLATIN + GEMCITABINE | 02 | N | 310008748 | GEMCARBO |
| 310006712 | 310003904 | 1.58 | null | Palliative (P) | 2015-12-11 | 2015-12-30 | Liposomal Doxorubicin (Caelyx) | N | null | 310008748 | LIPOSOMAL DOXORUBICIN |
| 310006713 | 310003905 | 1.78 | 74.7 | null | 2015-11-21 | 2015-11-30 | GemCarbo Days 1+8 | 2 | N | 310008767 | GEMCARBO |
| 310006714 | 310003905 | 1.78 | 89.6 | Neo-adjuvant (N) | 2012-12-21 | 2013-06-07 | Bevacizumab 7.5mg/kg | 1 | N | 310008767 | BEVACIZUMAB |
| 310006715 | 310003909 | 1.57 | 104 | Palliative (P) | 2015-11-03 | 2017-01-25 | Bevacizumab 7.5mg/kg | 99 | N | 310008825 | BEVACIZUMAB |
| 310006718 | 310003912 | 1.56 | 59 | Adjuvant (A) | 2014-12-21 | 2015-01-01 | CHOP - 21 days | N | null | 310008857 | CHOP |
| 310006719 | 310007610 | 1.75 | 63 | Curative (C) | 2018-03-23 | 2018-04-19 | CHOP - 21 days | 02 | N | 310008857 | CHOP |
| 310006720 | 310011702 | null | 91.9 | Palliative (P) | 2014-10-30 | 2015-03-06 | Bevacizumab 7.5mg/kg | 02 | N | 310008897 | BEVACIZUMAB |
| 310006722 | 310003920 | 1.64 | 71.6 | Palliative (P) | 2014-08-15 | 2014-09-09 | GEMCARBO | null | N | 310008941 | GEMCARBO |
| 310006723 | 310003920 | 1.61 | 100 | Palliative (P) | 2014-12-23 | 2015-01-27 | CHOP - 21 days | N | N | 310008941 | CHOP |
| 310006724 | 310003920 | 1.71 | 72.3 | Palliative (P) | 2017-05-29 | 2017-07-17 | Bevacizumab | 1 | N | 310008941 | BEVACIZUMAB |
| 310006725 | 310007612 | null | 71.2 | null | 2015-12-11 | 2016-01-02 | Liposomal Doxorubicin (Caelyx) | N | N | 310009019 | LIPOSOMAL DOXORUBICIN |
| 310006726 | 310007612 | 1.59 | 88.05 | Not known (9) | 2016-09-22 | 2016-10-02 | CHOP - 21 days | 02 | N | 310009019 | CHOP |
| 310006727 | 310007612 | 1.57 | 56.7 | Palliative (P) | 2015-05-02 | 2016-06-04 | Liposomal Doxorubicin 40mg/m2 | N | N | 310009019 | LIPOSOMAL DOXORUBICIN |
| 310006728 | 310007612 | 1.89 | 102 | null | 2015-03-19 | 2015-03-19 | GEMCARBO | 2 | N | 310009019 | GEMCARBO |
| 310006729 | 310003925 | null | 88.7 | Palliative (P) | 2018-01-09 | 2018-07-29 | CHOP | 1 | N | 310009084 | CHOP |
| 310006730 | 310007614 | 1.64 | null | Palliative (P) | 2015-04-22 | 2015-09-19 | Bevacizumab | 02 | N | 310009084 | BEVACIZUMAB |
| 310006731 | 310007614 | 1.58 | 68.6 | Palliative (P) | 2016-03-24 | 2016-03-30 | Bevacizumab | N | N | 310009084 | BEVACIZUMAB |
| 310006732 | 310007614 | 1.79 | null | Disease modification (D) | 2016-04-04 | 2016-04-26 | Liposomal Doxorubicin (Caelyx) | N | N | 310009084 | LIPOSOMAL DOXORUBICIN |
| 310006733 | 310011511 | null | 112 | Palliative (P) | 2016-05-28 | 2016-06-17 | Trial Unspecified | Y | N | 310009203 | TRIAL |
| 310006734 | 310003928 | 1.55 | 67.1 | Palliative (P) | 2015-02-28 | 2015-04-07 | GemCarbo Days 1+8 | 02 | N | 310009205 | GEMCARBO |
| 310006735 | 310003928 | 1.67 | 53.5 | Curative (C) | 2014-09-23 | 2014-09-28 | CHEMO-T TRIAL | N | N | 310009205 | TRIAL |
| 310006736 | 310003928 | null | 70.6 | Adjuvant (A) | 2013-11-04 | 2014-02-18 | CHOP | 02 | N | 310009205 | CHOP |
| 310006737 | 310003928 | 1.67 | 133 | Palliative (P) | 2014-09-13 | 2014-10-05 | Liposomal Doxorubicin (Caelyx) | N | N | 310009205 | LIPOSOMAL DOXORUBICIN |
| 310006741 | 310003932 | 1.71 | 53.3 | Curative (C) | 2017-06-14 | 2017-07-01 | CHOP - 21 days | N | N | 310009231 | CHOP |
| 310006743 | 310003936 | null | null | null | 2014-02-01 | 2014-02-09 | Bevacizumab | 02 | N | 310009279 | BEVACIZUMAB |
| 310006744 | 310003936 | null | 47.9 | Adjuvant (A) | null | 2015-07-03 | Bevacizumab 7.5mg/kg | N | N | 310009279 | BEVACIZUMAB |
| 310006745 | 310010604 | 1.72 | 147.6 | null | 2015-05-02 | 2015-05-23 | Bevacizumab | 1 | N | 310009347 | BEVACIZUMAB |
| 310006746 | 310011191 | 1.55 | 79.7 | Palliative (P) | 2014-04-29 | 2014-10-15 | Bevacizumab 7.5mg/kg | N | N | 310009386 | BEVACIZUMAB |
| 310006747 | 310003939 | 1.55 | 64.5 | Palliative (P) | 2015-08-10 | 2015-08-29 | Liposomal Doxorubicin (Caelyx) | null | N | 310009387 | LIPOSOMAL DOXORUBICIN |
| 310006748 | 310003940 | null | 66.4 | Adjuvant (A) | 2014-12-02 | 2014-12-02 | CHOP - 21 days | N | N | 310009394 | CHOP |
| 310006752 | 310003946 | 1.79 | 53.1 | Curative (C) | 2016-11-04 | 2016-12-17 | GEMCARBO | N | N | 310009438 | GEMCARBO |
| 310006753 | 310003949 | 1.69 | 45.5 | Adjuvant (A) | 2013-06-06 | 2014-03-20 | Bevacizumab | N | N | 310009438 | BEVACIZUMAB |
| 310006754 | 310003950 | 1.69 | 52 | Curative (C) | 2015-01-01 | 2015-01-04 | Trial Unspecified | null | null | 310009534 | TRIAL |
| 310006755 | 310007626 | 1.65 | 79 | null | 2015-09-10 | 2015-09-11 | GEMCARBO | 02 | N | 310009534 | GEMCARBO |
| 310006756 | 310003952 | 1.71 | 67.7 | Palliative (P) | 2012-10-02 | 2013-05-03 | CARBOPLATIN + GEMCITABINE | 2 | N | 310009598 | GEMCARBO |
| 310006757 | 310003953 | 1.65 | 82.2 | Curative (C) | 2018-03-19 | 2018-03-19 | Trial Unspecified | N | N | 310009650 | TRIAL |
| 310006758 | 310003955 | 1.5 | 109 | Palliative (P) | 2016-04-23 | 2016-05-15 | Trial Unspecified | Y | N | 310009657 | TRIAL |
| 310006759 | 310003955 | 1.77 | 70.3 | Palliative (P) | 2014-05-31 | 2014-06-15 | Trial Unspecified | 02 | N | 310009657 | TRIAL |
| 310006763 | 310003961 | 0 | 111 | Palliative (P) | 2014-11-04 | 2014-11-05 | Liposomal Doxorubicin (Caelyx) | N | null | 310009723 | LIPOSOMAL DOXORUBICIN |
| 310006764 | 310003963 | 1.89 | null | Palliative (P) | 2015-03-15 | 2015-03-25 | Liposomal Doxorubicin (Caelyx) | N | N | 310009738 | LIPOSOMAL DOXORUBICIN |
| 310006765 | 310003965 | 1.51 | 71 | Palliative (P) | 2013-01-05 | 2013-02-13 | GemCarbo Days 1+8 | N | N | 310009882 | GEMCARBO |
| 310006766 | 310007633 | 1.57 | 65.6 | Palliative (P) | 2017-09-06 | 2017-09-18 | Liposomal Doxorubicin (Caelyx) | 02 | N | 310009892 | LIPOSOMAL DOXORUBICIN |
| 310006767 | 310007633 | 1.58 | 67 | Palliative (P) | null | 2017-02-27 | GemCarbo Days 1+8 | N | N | 310009892 | GEMCARBO |
| 310006768 | 310011514 | 1.63 | 67.6 | null | 2013-08-06 | 2013-08-08 | CHOP - 14 days | N | N | 310009942 | CHOP |
| 310006769 | 310011514 | 1.57 | 95.2 | Palliative (P) | 2014-12-02 | 2015-05-05 | Bevacizumab 7.5mg/kg | N | N | 310009942 | BEVACIZUMAB |
| 310006770 | 310011514 | 1.55 | 56.15 | Not known (9) | 2016-07-24 | 2016-08-03 | LIPOSOMAL DOXORUBICIN | N | N | 310009942 | LIPOSOMAL DOXORUBICIN |
| 310006771 | 310003966 | 1.57 | 56.15 | Curative (C) | null | 2014-02-28 | CHOP - 21 days | N | null | 310010052 | CHOP |
| 310006772 | 310003968 | 1.64 | 55.9 | Palliative (P) | 2017-11-12 | 2017-11-14 | CARBOPLATIN + GEMCITABINE | N | null | 310010069 | GEMCARBO |
| 310006773 | 310007635 | null | 65.7 | Palliative (P) | null | 2014-08-10 | Trial Unspecified | 1 | N | 310010115 | TRIAL |